1. PARKINSON’S DISEASE Pharmacotherapeutics III By Sohel Memon (Doctor of Pharmacy) 2. TOPICS TO BE DISCUSSED 1.Definition2.Epidemiology3.Etiology4.Risk factor5.Types6.Signs…

1. - a neurological syndrome. 2. EPIDEMILOGY   In India there is a low prevalence of Parkinson’s disease. We find it in Parsi community of Mumbai. Even though…

1. INDEX Visit my web site at: http://www.yassermetwally.com/ INTRODUCTION  BASAL GANGLIA PATHOLOGICPROCESSES INTRODUCTIONComputed tomography (CT) and magnetic resonance…

1. Spinal Cord AnatomyDr.Saeed mustafa 2. • Runs through the vertebral canalSpinal Cord • Extends from foramen magnum to secondlumbar vertebra• Regions – Cervical…

ANTIPSYCHOTIC DRUGS (NEUROLEPTICS) PELTON-C-2 Constellation Workshop-IID * SOME DEFINITIONS Antipsychotics (also known as neuroleptics or major tranquilizers) are…

1. Parkinson Disease and Drugs associated with it By, Devansh Mehta M.Pharm.(Pharmacology) M.B.A.(Pharmaceutical marketing and Hospital Administration) B.Pharmacy Coordinates:…

1. Neurodegenerative diseases Dr. Hiwa K. Saaed, PhD Department of Pharmacology & Toxicology College of Pharmacy University of Sulaimani [email protected] 2014-15…

Slide 1Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia Basile et al (1999) NEUROPSYCHOPHARMACOLOG Y. 21 (1):…

American Association of Neuropathologists: 2011 Diagnostic Slide Session 2011-8 Jeremy Deisch, M.D. Dennis Burns, M.D. Charles White III, M.D. History 21-year-old female;…

B Basal Ganglia Objectives Understand the anatomical and functional definition of the basal ganglia. Identify the different components of the basal ganglia. Describe the…